{
    "id": 14175,
    "name": "von Hippel-Lindau disease",
    "source": "DOID",
    "definition": null,
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:14175",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT02108002",
            "title": "Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)",
            "phase": null,
            "recruitment": "Completed",
            "therapies": [
                {
                    "id": 1077,
                    "therapyName": "Vorinostat",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03401788",
            "title": "A Phase 2 Study of PT2977 for the Treatment of Von Hippel Lindau Disease-Associated Renal Cell Carcinoma",
            "phase": "Phase II",
            "recruitment": "Active, not recruiting",
            "therapies": [
                {
                    "id": 5820,
                    "therapyName": "PT 2977",
                    "synonyms": null
                }
            ]
        }
    ]
}